AAAAAA
Results:
1-17
|
Results: 17
Authors:
Robertson, RP
Citation: Rp. Robertson, Pancreatic islet transplantation for diabetes: Successes, limitations, andchallenges for the future, MOL GEN MET, 74(1-2), 2001, pp. 200-205
Authors:
Robertson, RP
Citation: Rp. Robertson, Insights into alloislets from successful autoislet transplantation in patients with chronic pancreatitis, J INVES MED, 49(6), 2001, pp. 563-565
Authors:
Paty, BW
Lanz, K
Kendall, DM
Sutherland, DER
Robertson, RP
Citation: Bw. Paty et al., Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation, TRANSPLANT, 72(6), 2001, pp. 1103-1107
Authors:
Robertson, RP
Citation: Rp. Robertson, Pancreatic islet cell transplantation - Likely impact on current therapeutics for type 1 diabetes mellitus, DRUGS, 61(14), 2001, pp. 2017-2020
Authors:
Harmon, JS
Gleason, CE
Tanaka, Y
Poitout, V
Robertson, RP
Citation: Js. Harmon et al., Antecedent hyperglycemia, not hyperlipidemia, is associated with increasedislet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats, DIABETES, 50(11), 2001, pp. 2481-2486
Authors:
Robertson, RP
Lanz, KJ
Sutherland, DER
Kendall, DM
Citation: Rp. Robertson et al., Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis, DIABETES, 50(1), 2001, pp. 47-50
Authors:
Sutherland, DER
Gruessner, RWG
Dunn, DL
Matas, AJ
Humar, A
Kandaswamy, R
Mauer, SM
Kennedy, WR
Goetz, FC
Robertson, RP
Gruessner, AC
Najarian, JS
Citation: Der. Sutherland et al., Lessons learned from more than 1,000 pancreas transplants at a single institution, ANN SURG, 233(4), 2001, pp. 463-501
Authors:
Robertson, RP
Harmon, J
Tananka, Y
Sacchi, G
Tran, POT
Gleason, C
Poitout, V
Citation: Rp. Robertson et al., Glucose toxicity of the pancreatic beta-cell, ENDOC UPD S, 11, 2001, pp. 47-66
Authors:
Gleason, CE
Gonzalez, M
Harmon, JS
Robertson, RP
Citation: Ce. Gleason et al., Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15, AM J P-ENDO, 279(5), 2000, pp. E997-E1002
Authors:
Robertson, RP
Davis, C
Larsen, J
Stratta, R
Sutherland, DER
Citation: Rp. Robertson et al., Pancreas and islet transplantation for patients with diabetes, DIABET CARE, 23(1), 2000, pp. 112-116
Authors:
Robertson, RP
Citation: Rp. Robertson, Successful islet transplantation for patients with diabetes - fact or fantasy?, N ENG J MED, 343(4), 2000, pp. 289-290
Authors:
Robertson, RP
Citation: Rp. Robertson, Islet transplantation: where are we?, DIABETES ANNUAL/13, 2000, pp. 65-76
Authors:
Robertson, RP
Citation: Rp. Robertson, Prevention of recurrent hypoglycemia in type 1 diabetes by pancreas transplantation, ACT DIABETO, 36(1-2), 1999, pp. 3-9
Authors:
Tanaka, Y
Gleason, CE
Tran, POT
Harmon, JS
Robertson, RP
Citation: Y. Tanaka et al., Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants, P NAS US, 96(19), 1999, pp. 10857-10862
Authors:
Tran, POT
Gleason, CE
Poitout, V
Robertson, RP
Citation: Pot. Tran et al., Prostaglandin E-2 mediates inhibition of insulin secretion by interleukin-1 beta, J BIOL CHEM, 274(44), 1999, pp. 31245-31248
Authors:
Robertson, RP
Sutherland, DER
Lanz, KJ
Citation: Rp. Robertson et al., Normoglycemia and preserved insulin secretory reserve in diabetic patients10-18 years after pancreas transplantation, DIABETES, 48(9), 1999, pp. 1737-1740
Authors:
Harmon, JS
Gleason, CE
Tanaka, Y
Oseid, EA
Hunter-Berger, KK
Robertson, RP
Citation: Js. Harmon et al., In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression, DIABETES, 48(10), 1999, pp. 1995-2000
Risultati:
1-17
|